European Organisation for
Research and Treatment of Cancer

Active for
60+ years

Network of
3800+ members

Present in
50+ countries

100+ active
studies

20+ recruiting
studies

250+ experts
in HQ

Latest news

  • EORTC ATOM trial

    EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma

    11 Dec 2024

  • Belgian Health Minister visits EORTC HQ

    Minister F. Vandenbroucke visits EORTC Headquarters to strengthen collaborative efforts in clinical cancer research

    21 Nov 2024

  • Immucan - patient enrolment

    IMMUcan has completed patient enrolment

    12 Nov 2024

Projects

SPECTA

E²-RADIATE

RECIST

Latest publications

Upcoming events

  • EORTC Brain Tumour Group Spring Meeting

    21 Feb - 21 Feb 2025

    EORTC HQ, Brussels, Belgium

  • Melanoma Group

    EORTC Melanoma Group Spring Meeting 2025

    20 Mar - 21 Mar 2025

    Frankfurt, Germany

    • Past events

  • 36th EORTC-NCI-AACR Symposium - Banner

    36th EORTC-NCI-AACR Symposium

    23 Oct - 25 Oct 2024

    Barcelona, Spain

  • Clinical Trial Statistics for Non-Statisticians

    Clinical Trial Statistics for Non-Statisticians

    11 Jun - 14 Jun 2024

    Brussels, BE

    • Highlights

    • EORTC Annual Report 2023

      Publication of 2023 EORTC Annual Report

    • Manifesto - Illustration

      Manifesto

    • EORTC Practice Changing Trials

      Practice Changing Trials

    • EORTC Cancer Research Fund

      ECRF

      EORTC Cancer Research Fund